GE, VirtualScopics to study PET biomarkers

Manjula Puthenedam, PhD, | | Health Imaging | Molecular Imaging
VirtualScopics is partnering with GE Healthcare's Medical Diagnostics Imanet unit to study PET imaging biomarkers used in drug development.

The collaboration of VirtualScopics and GE's Imanet would provide customers in vivo detection and advanced analysis of more than 40 PET imaging biomarkers for drug research in a variety of disease pathways, including oncology, said the Rochester, N.Y.-based VirtualScopics. The combined competencies of both companies in PET, MRI, CT and ultrasound could help play a role in identifying targets for patient stratification and treatment, the company added.

Manjula Puthenedam, PhD,

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.